Stitch closes £2.5m Seed funding to create the definitive patient retention platform for clinical trials

We’re thrilled to announce we’ve raised £2.5m of Seed funding, led by Connect Ventures, with participation from Form Ventures, Boost Capital, and exceptional angel investors.

At Stitch, we’re on a mission to make clinical trials better by measuring each patient’s experience. Our platform helps patients manage their trial journey and share their feedback. Enabling research sponsors to improve patient experience, trial design, and retain more patients on trial.

Sitar Teli, Managing Partner at Connect Ventures, comments:

"Patients are the critical participants in clinical trials, but their experience is one of poor communication, frustration and neglect. Stitch is building the first truly patient-centric product for clinical trials. It enables sponsors to communicate trial protocol clearly and conveniently; and patients to give feedback on their experience in real-time, improving patient retention and success rates.”

Jonathan Moshinsky, Co-Founder & CEO of Stitch says:

“It’s fantastic to be working with such an exceptional partner, Connect Ventures, who share our vision of a world where each patient on every clinical trial is supported and heard throughout their journey”.